BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20163376)

  • 21. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
    Girelli CM; Mirata C; Casiraghi A
    Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
    Kronenberger B; Wagner M; Herrmann E; Mihm U; Piiper A; Sarrazin C; Zeuzem S
    J Viral Hepat; 2005 May; 12(3):307-14. PubMed ID: 15850472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
    Hu KQ; Schiff ER; Kowdley KV; Min AD; Shiffman ML; Lee WM; Goodman ZD; Dau LO; Peschell KJ; Fagan EA; Flaherty JF
    J Clin Gastroenterol; 2010 Aug; 44(7):510-6. PubMed ID: 20179614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
    Elsebae MM; Abu-Zekri NB
    Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy.
    Pockros PJ; Patel K; O'Brien C; Tong M; Smith C; Rustgi V; Carithers RL; McHutchison JG; Olek E; Debruin MF
    Hepatology; 2003 Jun; 37(6):1368-74. PubMed ID: 12774016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
    Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
    Shiffman ML; Stewart CA; Hofmann CM; Contos MJ; Luketic VA; Sterling RK; Sanyal AJ
    J Infect Dis; 2000 Dec; 182(6):1595-601. PubMed ID: 11069229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
    Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
    J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amantadine-HCL in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load].
    Parolin MB; Lacerda MA; Lopes RW
    Arq Gastroenterol; 1999; 36(2):63-7. PubMed ID: 10511883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological features of liver and its relation to serum transaminase levels in 91 cases of anti-HBe-positive chronic hepatitis B.
    Hasanjani Roushan MR; Hajiahmadi M; Shafaie S
    Int J Clin Pract; 2005 Jul; 59(7):791-4. PubMed ID: 15963206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
    Huber R; Lüdtke R; Klassen M; Müller-Buscher G; Wolff-Vorbeck G; Scheer R
    Eur J Med Res; 2001 Sep; 6(9):399-405. PubMed ID: 11669085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C.
    Batdelger D; Dandii D; Jirathitikal V; Bourinbaiar AS
    Vaccine; 2008 May; 26(22):2733-7. PubMed ID: 18455842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease.
    Shiffman M; Freilich B; Vuppalanchi R; Watt K; Chan JL; Spada A; Hagerty DT; Schiff E
    Aliment Pharmacol Ther; 2019 Jan; 49(1):64-73. PubMed ID: 30430605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological status of the liver in relation to serum aminotransferase levels in patients with chronic hepatitis C.
    Bartos V; Krkoska D; Slavik P; Lauko L; Adamkov M
    Bratisl Lek Listy; 2007; 108(12):522-5. PubMed ID: 18309644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial.
    Raymond RS; Fallon MB; Abrams GA
    Ann Intern Med; 1998 Nov; 129(10):797-800. PubMed ID: 9841585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aspartate aminotransferase (AST), alanine aminotransferase (ALT)].
    Abei M
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():348-51. PubMed ID: 15628414
    [No Abstract]   [Full Text] [Related]  

  • 40. [Aspartate aminotransferase (AST) and alanine aminotransferase (ALT)].
    Miura Y
    Nihon Rinsho; 1999 Aug; 57 Suppl():320-5. PubMed ID: 10503432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.